Internal medicine, Rheumatoid arthritis, Rheumatology, Surgery and Arthritis are his primary areas of study. The Internal medicine study combines topics in areas such as Gastroenterology and Physical therapy. His biological study spans a wide range of topics, including Infliximab and Disease.
His Rheumatology study incorporates themes from Transcutaneous electrical nerve stimulation, Manual therapy, Diacerein, Electrotherapy and Pharmacology. His studies deal with areas such as Stroke, Adverse effect and Cohort as well as Surgery. His study in Arthritis is interdisciplinary in nature, drawing from both Psoriasis, Endocrinology, Forceps and Pathology.
His scientific interests lie mostly in Internal medicine, Rheumatoid arthritis, Immunology, Rheumatology and Arthritis. His Internal medicine study combines topics in areas such as Gastroenterology and Surgery. His research related to Prednisone and Prospective cohort study might be considered part of Surgery.
His research integrates issues of Physical therapy, Adverse effect and Clinical trial in his study of Rheumatoid arthritis. His work in Autoantibody, Antibody, Connective tissue disease, Inflammation and Pathogenesis is related to Immunology. His Arthritis research is multidisciplinary, relying on both Infliximab and Etanercept.
His primary areas of study are Internal medicine, Rheumatoid arthritis, Rheumatology, Disease and Cohort. Roberto Caporali integrates Internal medicine and In patient in his research. His study of Rheumatoid factor is a part of Rheumatoid arthritis.
His studies in Rheumatology integrate themes in fields like Systematic review, Randomized controlled trial and Clinical trial. His research in Disease intersects with topics in Epidemiology and Family medicine. While the research belongs to areas of Adverse effect, he spends his time largely on the problem of Tocilizumab, intersecting his research to questions surrounding Prednisone.
Roberto Caporali mainly focuses on Internal medicine, Coronavirus disease 2019, Pandemic, Rheumatoid arthritis and Disease. Internal medicine is closely attributed to Referral in his research. His Pandemic research includes themes of Incidence, Pneumonia, Outbreak, Emergency medicine and Global health.
His Rheumatoid arthritis study combines topics from a wide range of disciplines, such as Pregnancy, Arthritis, Immune system, Biomarker and Active inflammation. His Arthritis study deals with the bigger picture of Immunology. His work deals with themes such as Risk factor and Intensive care medicine, which intersect with Disease.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Osteoarthritis: An Overview of the Disease and Its Treatment Strategies
Piercarlo Sarzi-Puttini;Marco A. Cimmino;Raffaele Scarpa;Roberto Caporali.
Seminars in Arthritis and Rheumatism (2005)
COVID-19 infection and rheumatoid arthritis: Faraway, so close!
Ennio Giulio Favalli;Francesca Ingegnoli;Orazio De Lucia;Gilberto Cincinelli.
Autoimmunity Reviews (2020)
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group
Jérôme Avouac;J. Fransen;U. A. Walker;V. Riccieri.
Annals of the Rheumatic Diseases (2011)
Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse
Carlo A. Scirè;Carlomaurizio Montecucco;Veronica Codullo;Oscar Epis.
Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis.
Antonio Manzo;Samantha Paoletti;Maresa Carulli;Mark C Blades.
European Journal of Immunology (2005)
Reliability and validity of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index in Italian patients with osteoarthritis of the knee
F. Salaffi;G. Leardini;B. Canesi;A. Mannoni.
Osteoarthritis and Cartilage (2003)
Prednisone plus Methotrexate for Polymyalgia Rheumatica: A Randomized, Double-Blind, Placebo-Controlled Trial
Roberto Caporali;Marco A. Cimmino;Gianfranco Ferraccioli;Roberto Gerli.
Annals of Internal Medicine (2004)
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)
Raphaèle Seror;Raphaèle Seror;Hendrika Bootsma;Alain Saraux;Simon J Bowman.
Annals of the Rheumatic Diseases (2016)
EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide.
Raphaèle Seror;Simon J Bowman;Pilar Brito-Zeron;Elke Theander.
RMD Open (2015)
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment
Francesca Bobbio-Pallavicini;Claudia Alpini;Roberto Caporali;Stefano Avalle.
Arthritis Research & Therapy (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: